Shanxi Panlong Pharmaceutical Group Co., Ltd. has approved the repurchase and cancellation of all restricted stocks, resulting in a reduction of total shares from 106,280,960 to 105,154,560. The registered capital will decrease from RMB 106,280,960 to RMB 105,154,560. Creditors are notified to claim debts within specified periods following this announcement.
Summary generated by AI · Always verify with source document
Securities Code: 002864
Securities Abbreviation: Panlong Pharmaceutical
Announcement Number: 2026-031
Shanxi Panlong Pharmaceutical Group Co., Ltd. announces the repurchase and cancellation of all restricted stocks and the reduction of registered capital. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.